Wai Yuen Tong Medicine Holdings Ltd. Annual Results: Standalone & Consolidated Reports

Annual Results

Results Snapshot

Figures in Million

Consolidate Annual Results

Mar'25

Mar'24

Mar'23

Mar'22

Mar'21

Mar'20

Mar'19

Net Sales

745.30

783.88

723.60

1,391.41

1,108.57

620.74

751.44

Other Operating Income

0.00

Total Operating income

745.30

783.88

723.60

1,391.41

1,108.57

620.74

751.44

Raw Material Cost

368.85

389.07

381.24

817.26

660.31

338.50

449.92

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

242.57

231.39

144.29

214.89

210.93

175.56

175.15

Power Cost

0.00

Manufacturing Expenses

28.16

40.79

29.50

95.69

107.72

52.78

28.55

Selling and Distribution Expenses

423.44

352.15

335.43

516.66

467.26

405.80

433.90

Other Expenses

-26.96

-27.04

-17.19

-30.93

-31.37

-21.75

-19.58

Total Expenditure (Excl Depreciation)

793.41

743.00

718.56

1,335.22

1,132.54

755.15

891.72

Operating Profit (PBDIT) excl Other Income

-48.099999999999994

40.9

56.2

-24

-134.4

-140.29999999999998

Other Income

68.49

73.91

47.65

103.53

-129.49

835.11

157.16

Operating Profit (PBDIT)

110.87

203.96

147.91

267.49

-60.19

813.34

68.21

Interest

28.16

40.79

29.50

95.69

107.72

52.78

28.55

Exceptional Items

10.81

-90.16

-32.03

-112.88

-47.25

-207.90

93.36

Gross Profit (PBDT)

376.45

394.81

342.36

574.15

448.26

282.24

301.53

Depreciation

90.48

89.17

95.23

107.80

92.62

112.67

51.32

Profit Before Tax

3.03

-16.17

-8.85

-48.88

-307.79

439.99

81.69

Tax

-3.02

-6.36

-13.32

40.52

148.13

17.20

7.45

Provisions and contingencies

0.00

Profit After Tax

7.10

-26.68

-16.45

-108.91

-376.00

438.55

74.63

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

7.10

-26.68

-16.45

-108.91

-376.00

438.55

74.63

Share in Profit of Associates

0.00

Minority Interest

-0.01

19.40

23.86

21.09

-75.27

-0.58

-0.38

Other related items

0.00

Consolidated Net Profit

7.09

-7.27

7.41

-87.82

-451.26

437.97

74.25

Equity Capital

0.00

Face Value

0.01

Reserves

1,181.07

1,386.95

2,349.19

2,515.80

2,565.32

2,642.79

2,444.12

Earnings per share (EPS)

0.01

-0.01

-0.02

-0.09

-0.31

0.36

0.06

Diluted Earnings per share

0.01

-0.01

-0.02

-0.09

-0.31

0.36

0.06

Operating Profit Margin (Excl OI)

-6.46%

5.22%

0.7%

4.04%

-2.1%

-21.66%

-18.67%

Gross Profit Margin

12.55%

9.31%

11.94%

4.23%

-19.41%

89.03%

17.7%

PAT Margin

0.95%

-3.4%

-2.27%

-7.83%

-33.92%

70.65%

9.93%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Annual Analysis Highlights

Net Sales

YoY Growth in year ended Mar 2025 is -4.92% vs 8.33% in Mar 2024

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 197.26% vs -198.65% in Mar 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -67.41% vs 29.71% in Mar 2024

Interest

YoY Growth in year ended Mar 2025 is -30.88% vs 38.31% in Mar 2024

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has fallen from Mar 2024

Compare Annual Results Of Wai Yuen Tong Medicine Holdings Ltd. With

Select Peers

Figures in Million

Consolidate Annual Results

Change(HKD)

Change(%)

Net Sales

745.30

9,462.95

-8,717.65

-92.12%

Other Operating Income

0.00

Total Operating income

745.30

9,462.95

-8,717.65

-92.12%

Raw Material Cost

368.85

7,885.88

-7,517.03

-95.32%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

242.57

0.00

242.57

Power Cost

0.00

Manufacturing Expenses

28.16

48.24

-20.08

-41.63%

Selling and Distribution Expenses

423.44

716.79

-293.35

-40.93%

Other Expenses

-26.96

34.59

-61.55

-177.94%

Total Expenditure (Excl Depreciation)

793.41

8,996.80

-8,203.39

-91.18%

Operating Profit (PBDIT) excl Other Income

-48.11

466.14

-514.25

-110.32%

Other Income

68.49

46.11

22.38

48.54%

Operating Profit (PBDIT)

110.87

1,076.66

-965.79

-89.70%

Interest

28.16

48.24

-20.08

-41.63%

Exceptional Items

10.81

3.32

7.49

225.60%

Gross Profit (PBDT)

376.45

1,577.07

-1,200.62

-76.13%

Depreciation

90.48

641.89

-551.41

-85.90%

Profit Before Tax

3.03

389.84

-386.81

-99.22%

Tax

-3.02

57.06

-60.08

-105.29%

Provisions and contingencies

0.00

Profit After Tax

7.10

314.39

-307.29

-97.74%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

7.10

314.39

-307.29

-97.74%

Share in Profit of Associates

0.00

Minority Interest

-0.01

17.80

-17.81

-100.06%

Other related items

0.00

Consolidated Net Profit

7.09

332.19

-325.10

-97.87%

Equity Capital

0.00

Face Value

0.01

1.11

0.00

Reserves

1,181.07

5,801.58

-4,620.51

-79.64%

Earnings per share (EPS)

0.01

0.45

-0.44

-97.78%

Diluted Earnings per share

0.01

0.45

-0.44

-97.78%

Operating Profit Margin (Excl OI)

-6.46%

4.11%

0.00

-10.57%

Gross Profit Margin

12.55%

10.90%

0.00

1.65%

PAT Margin

0.95%

3.32%

0.00

-2.37%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Annual - Net Sales

Net Sales 74.53 Million

in Mar 2025

Figures in Million

YoY Growth in year ended Mar 2025 is -4.92% vs 8.33% in Mar 2024

Annual - Consolidate Net Profit

Consolidate Net Profit 0.71 Million

in Mar 2025

Figures in Million

YoY Growth in year ended Mar 2025 is 197.26% vs -198.65% in Mar 2024

Annual - Operating Profit (PBDIT)

Operating Profit (PBDIT) 4.24 Million

in Mar 2025

Figures in Million

YoY Growth in year ended Mar 2025 is -67.41% vs 29.71% in Mar 2024

Annual - Interest

Interest 2.82 Million

in Mar 2025

Figures in Million

YoY Growth in year ended Mar 2025 is -30.88% vs 38.31% in Mar 2024

Annual - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) -6.46%

in Mar 2025

Figures in %

YoY Growth in year ended Mar 2025 has fallen from Mar 2024